News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,398 Results
Type
Article (42218)
Company Profile (296)
Press Release (670884)
Section
Business (210381)
Career Advice (2094)
Deals (36623)
Drug Delivery (105)
Drug Development (82975)
Employer Resources (172)
FDA (16536)
Job Trends (15386)
News (355854)
Policy (33864)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (6)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2584)
Accelerated approval (2)
Adcomms (21)
Allergies (80)
Alliances (51340)
ALS (77)
Alzheimer's disease (1339)
Antibody-drug conjugate (ADC) (106)
Approvals (16521)
Artificial intelligence (224)
Autoimmune disease (10)
Automation (14)
Bankruptcy (367)
Best Places to Work (11772)
BIOSECURE Act (19)
Biosimilars (98)
Biotechnology (190)
Bladder cancer (50)
Brain cancer (24)
Breast cancer (234)
Cancer (1812)
Cardiovascular disease (139)
Career advice (1748)
Career pathing (29)
CAR-T (132)
Cell therapy (377)
Cervical cancer (13)
Clinical research (66917)
Collaboration (712)
Compensation (388)
Complete response letters (24)
COVID-19 (2640)
CRISPR (36)
C-suite (179)
Cystic fibrosis (100)
Data (1714)
Decentralized trials (2)
Denatured (24)
Depression (38)
Diabetes (225)
Diagnostics (6386)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (105)
Drug pricing (105)
Drug shortages (26)
Duchenne muscular dystrophy (63)
Earnings (87378)
Editorial (29)
Employer branding (21)
Employer resources (148)
Events (114058)
Executive appointments (602)
FDA (17512)
Featured Employer (54)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (634)
Gene editing (90)
Generative AI (20)
Gene therapy (270)
GLP-1 (695)
Government (4485)
Grass and pollen (4)
Guidances (44)
Healthcare (18969)
Huntington's disease (23)
IgA nephropathy (20)
Immunology and inflammation (94)
Indications (24)
Infectious disease (2759)
Inflammatory bowel disease (128)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (71)
Interviews (322)
IPO (16745)
IRA (46)
Job creations (4054)
Job search strategy (1493)
Kidney cancer (9)
Labor market (26)
Layoffs (464)
Leadership (15)
Legal (8358)
Liver cancer (69)
Lung cancer (261)
Lymphoma (121)
Machine learning (2)
Management (58)
Manufacturing (254)
MASH (59)
Medical device (13371)
Medtech (13376)
Mergers & acquisitions (20268)
Metabolic disorders (595)
Multiple sclerosis (58)
NASH (17)
Neurodegenerative disease (72)
Neuropsychiatric disorders (25)
Neuroscience (1779)
NextGen: Class of 2025 (6640)
Non-profit (4526)
Northern California (2212)
Now hiring (35)
Obesity (328)
Opinion (221)
Ovarian cancer (62)
Pain (78)
Pancreatic cancer (69)
Parkinson's disease (117)
Partnered (17)
Patents (181)
Patient recruitment (79)
Peanut (48)
People (58927)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20747)
Phase II (29448)
Phase III (22061)
Pipeline (806)
Podcasts (69)
Policy (109)
Postmarket research (2654)
Preclinical (8775)
Press Release (68)
Prostate cancer (85)
Psychedelics (31)
Radiopharmaceuticals (247)
Rare diseases (347)
Real estate (6248)
Recruiting (66)
Regulatory (22844)
Reports (43)
Research institute (2364)
Resumes & cover letters (360)
Rett syndrome (2)
RNA editing (1)
RSV (36)
Schizophrenia (66)
Series A (116)
Series B (69)
Service/supplier (12)
Sickle cell disease (52)
Southern California (1891)
Special edition (14)
Sponsored (29)
Startups (3719)
State (2)
Stomach cancer (12)
Supply chain (56)
The Weekly (44)
United States (19511)
Vaccines (642)
Venture capitalists (34)
Webinars (12)
Weight loss (230)
Women's health (30)
Worklife (13)
Date
Today (191)
Last 7 days (806)
Last 30 days (2933)
Last 365 days (34894)
2025 (5630)
2024 (35775)
2023 (40634)
2022 (51801)
2021 (56336)
2020 (54799)
2019 (47410)
2018 (35779)
2017 (33140)
2016 (32665)
2015 (38621)
2014 (32518)
2013 (27633)
2012 (29735)
2011 (30487)
2010 (28500)
Location
Africa (780)
Alabama (48)
Alaska (7)
Arizona (218)
Arkansas (13)
Asia (40439)
Australia (6477)
California (5038)
Canada (1766)
China (423)
Colorado (232)
Connecticut (239)
Delaware (113)
Europe (86211)
Florida (742)
Georgia (172)
Idaho (57)
Illinois (475)
India (21)
Indiana (281)
Iowa (7)
Japan (130)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (59)
Maryland (774)
Massachusetts (3864)
Michigan (203)
Minnesota (347)
Mississippi (2)
Missouri (70)
Montana (28)
Nebraska (25)
Nevada (54)
New Hampshire (61)
New Jersey (1429)
New Mexico (28)
New York (1436)
North Carolina (881)
North Dakota (7)
Northern California (2212)
Ohio (176)
Oklahoma (13)
Oregon (37)
Pennsylvania (1144)
Puerto Rico (6)
Rhode Island (23)
South America (1159)
South Carolina (13)
South Dakota (1)
Southern California (1891)
Tennessee (83)
Texas (739)
Utah (157)
Virginia (124)
Washington D.C. (54)
Washington State (485)
West Virginia (3)
Wisconsin (46)
713,398 Results for "acumen pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights
Acumen Pharmaceuticals, Inc. reported financial results for the first quarter of 2024 and provided a business update.
May 14, 2024
·
12 min read
Press Releases
Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference
November 12, 2024
·
1 min read
BioCapital
Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) announced today that management will participate in a fireside chat at the 2024 Bank of America Healthcare Conference on Wednesday, May 15, 2024, at 8:55 a.m. PT (11:55 a.m. ET).
May 8, 2024
·
1 min read
Business
Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, announced that the Company will report first quarter 2024 financial results on Tuesday, May 14, 2024.
May 7, 2024
·
1 min read
Press Releases
Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference
November 7, 2024
·
1 min read
Press Releases
Acumen Pharmaceuticals Announces Journal of Prevention of Alzheimer’s Disease Publication of the Company’s Phase 1 INTERCEPT-AD Study, Including Target Engagement, Dosing Regimen and Safety Findings
January 9, 2025
·
7 min read
BioCapital
Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) announced today that management will participate in a fireside chat at the H.C. Wainwright 2nd Annual BioConnect Conference on Monday, May 20, 2024, at 12:30 p.m. ET.
May 13, 2024
·
1 min read
BioCapital
Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) announced today that management will participate in a fireside chat as part of the Stifel 2024 CNS Days on Tuesday, March 19, 2024, at 12:00 p.m. ET.
March 12, 2024
·
1 min read
Press Releases
Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference
November 26, 2024
·
1 min read
Press Releases
Acumen Health Holdings (“Acumen”) to Acquire the Avenova brand from NovaBay Pharmaceuticals
September 20, 2024
·
2 min read
1 of 71,340
Next
